Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PTC THERAPEUTICS, INC. | Director | Common Stock | 15.2K | $686K | $45.16 | Jan 3, 2025 | Direct |
PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 8.8K | $238K | $27.05 | Jan 3, 2025 | Direct |
Aadi Bioscience, Inc. | Director | Stock Option (right to buy) | 45.8K | Jun 12, 2024 | Direct | ||
Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25K | May 30, 2024 | Direct | ||
CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Stock Options (Right to buy) | 0 | Jul 15, 2021 | Direct |